Resources

Publications, application notes and more

  • Blog10 October 2019

    Drug Target Review webinar: Q&A session

    Don't worry if you missed our recent webinar with Drug Target Review, we have transcribed the Q&A session with speaker Dr Sean Devenish in this blog.

  • Blog09 October 2019

    Q&A session from BSI 2019

    Fluidic Analytics is proud to be a part of the first French congress of Structural Integrative Biology (BSI-2019), hosted at Paul Sabatier University in Toulouse. In this blog we have transcribed the Q&A part of the presentation that we gave on 8th October.

  • Video13 August 2019

    Conference Poster Presentations 2019

    Throughout 2019 we will be attending conferences all over the world and seeking out research topics and poster presetations we really think are worth taking a look at. Check back here regularly for videos of poster presentations that present cutting edge science from around the globe.

  • Video12 August 2019

    Measuring IL2 Stability in different buffers using Microfluidic Diffusional Sizing (MDS)

    In this video we look at how a commercially available human interleukin-2 is assessed by microfluidic diffusional sizing on the Fluidity One across a dilution series. The hydrodynamic radius is observed to increase with increasing concentration, in a way which suggests a monomer-trimer equilibrium with positive cooperativity is established.

  • Blog24 May 2019

    5 great reads: Protein-protein interactions and disease

    Here are five of our favorite recent publications, highlighting both the role of protein-protein interactions in disease and how the characterization of these interactions may allow the development of new therapeutic strategies.

  • Blog17 July 2018

    What biophysical attributes of biopharmaceuticals are measured, and why?

    An array of characteristics must be investigated in new biopharmaceuticals to evaluate their safety, efficacy and behaviour under changing conditions. Here we look at what specific attributes should be measured and why.